1. Home
  2. INDV vs ADMA Comparison

INDV vs ADMA Comparison

Compare INDV & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$33.38

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$18.08

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDV
ADMA
Founded
1994
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INDV
ADMA
Price
$33.38
$18.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$35.75
$28.50
AVG Volume (30 Days)
3.1M
2.3M
Earning Date
02-19-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
205.35
EPS
0.98
0.86
Revenue
$1,180,000,000.00
$488,559,000.00
Revenue This Year
$1.26
$22.19
Revenue Next Year
N/A
$23.71
P/E Ratio
$34.65
$20.68
Revenue Growth
N/A
27.63
52 Week Low
$7.62
$13.50
52 Week High
$38.00
$25.67

Technical Indicators

Market Signals
Indicator
INDV
ADMA
Relative Strength Index (RSI) 36.58 46.89
Support Level $33.76 $16.24
Resistance Level $36.22 $18.33
Average True Range (ATR) 1.14 0.72
MACD -0.46 -0.17
Stochastic Oscillator 7.10 55.15

Price Performance

Historical Comparison
INDV
ADMA

About INDV Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: